AbbVie seeks to stop EU agency releasing drug data

Sun Mar 10, 2013 6:11pm EDT

(Reuters) - AbbVie (ABBV.N), a pharmaceutical company has sought an injunction to block Europe's medicines regulator from releasing "confidential" and "commercially-sensitive" information on its blockbuster rheumatoid arthritis drug, a spokeswoman for the U.S. drugmaker confirmed on Sunday.

The Financial Times reported earlier on Sunday that the Chicago-based company, which was spun off from Abbott Laboratories (ABT.N), had taken legal action against the European Medicines Agency to stop it from releasing data on the effects in individual patients in clinical trials for its drug Humira.

The European Medicines Agency could not be reached for comment.

Sales of the drug, by far the company's biggest product, jumped 17 percent last year to $9.27 billion.

The European Medicines Agency, criticized in the past for excessive secrecy, is opening its data vaults to systematic scrutiny, a move that will let independent researchers trawl through millions of pages of clinical trial information.

It is blow for the pharmaceutical industry, which guards its commercial secrets fiercely and has not before been required to share its data with outside researchers.

(Reporting by Karen Rebelo in Bangalore; Editing by Diane Craft)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video